The Role of Quantitative Bone Scanning in the Assessment of Bone Turnover in Patients with Charcot Foot
- Robert Bem, MD, PHD (bemrob{at}yahoo.co.uk)1,
- Alexandra Jirkovská, MD, PHD1,
- Michal Dubský, MD1,
- Vladimira Fejfarová, MD, PHD1,
- Marie Buncová, MD, PHD2,
- Jelena Skibová1 and
- Edward B. Jude, MD, FRCP3
- 1 Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 2 Department of Nuclear Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 3 Diabetes Centre, Tameside General Hospital, Ashton-Under-Lyne, Lancashire, UK
Abstract
Objective: To assess the new quantitative bone scan parameters as markers of Charcot neuroosteoarthropathy (CNO) activity.
Reasearch Design And Methods: Forty-two patients with acute (n=21) and non-acute (n=21) CNO underwent quantitative bone scanning. Patients with acute CNO were followed for 3-12 months and bone scans were repeated after treatment. New quantitative parameters were assessed and compared with markers of bone turnover and with skin temperature difference (STD).
Results: Significant correlations between quantitative bone scan parameters and bone turnover markers were observed (all p<0.05). These parameters decreased after treatment of CNO and its reduction to the baseline value correlated with differences of bone turnover markers and STD (all p<0.05).
Conclusions: Our study suggests that bone scanning can be used not only for diagnosis of CNO, but also for monitoring disease activity by quantitative bone scan parameters.
Footnotes
-
- Received May 26, 2009.
- Accepted November 14, 2009.
- Copyright © American Diabetes Association











